Andrew Einhorn joins Relief as chief financial officer (CFO). Mr. Einhorn brings extensive experience from senior leadership roles within clinical and commercial-stage life science companies. From ...

GENEVA, SWITZERLAND / ACCESSWIRE / November 7, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTD) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, ...

Relief Therapeutics (OTCQB:RLFTY) Wednesday reported the formation of its new executive committee, with the appointment of several new members, including a chief financial officer, chief human ...

GENEVA, SWITZERLAND / ACCESS Newswire / August 11, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to ...

Relief Therapeutics Announces Publication of Plain Language Summary on PKU GOLIKE 29.10.2024 / 07:00 CET/CEST Relief Therapeutics Announces Publication of Plain Language Summary on PKU GOLIKE GENEVA ...

GENEVA (DEC. 27, 2024) – RELIEF THERAPEUTICS Holding SA RLFRLFTFRLFTY (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, ...

GENEVA and LAUSANNE (Oct. 8, 2025) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief or the Company), a biopharmaceutical company committed to delivering innovative treatment ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from RELIEF ...

ZURICH, Feb 8 (Reuters) - Relief Therapeutics Holding (RLFB.S), opens new tab expects top-line data from a trial of RLF-100 used intravenously in patients with COVID-19 to be released this month, the ...

Relief Therapeutics Announces New Executive Leadership Team strengthening capabilities to guide the Company through pipeline development initiatives 08-May-2024 / 07:00 CET/CEST Release of an ad hoc ...